IL90058A0 - Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies - Google Patents
Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodiesInfo
- Publication number
- IL90058A0 IL90058A0 IL90058A IL9005889A IL90058A0 IL 90058 A0 IL90058 A0 IL 90058A0 IL 90058 A IL90058 A IL 90058A IL 9005889 A IL9005889 A IL 9005889A IL 90058 A0 IL90058 A0 IL 90058A0
- Authority
- IL
- Israel
- Prior art keywords
- peptide
- pharmaceutical compositions
- directed against
- hiv envelope
- monoclonal antibodies
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18633388A | 1988-04-26 | 1988-04-26 | |
US07/324,027 US5562905A (en) | 1988-04-26 | 1989-03-20 | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
Publications (1)
Publication Number | Publication Date |
---|---|
IL90058A0 true IL90058A0 (en) | 1989-12-15 |
Family
ID=26881983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL90058A IL90058A0 (en) | 1988-04-26 | 1989-04-24 | Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0339504A3 (no) |
JP (1) | JPH02160800A (no) |
AU (1) | AU632475B2 (no) |
DK (1) | DK200189A (no) |
FI (1) | FI891957A (no) |
HU (1) | HUT51296A (no) |
IL (1) | IL90058A0 (no) |
NO (1) | NO891711L (no) |
NZ (1) | NZ228869A (no) |
PT (1) | PT90376B (no) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2097759T3 (es) * | 1989-04-25 | 1997-04-16 | Tanox Biosystems Inc | Anticuerpos especificos para el dominio de fijacion de cd4 de hiv. |
PT94276A (pt) * | 1989-06-05 | 1991-02-08 | Anticorpo monoclonal capaz de neutralizar o prototipo mn de hiv | |
SE9000333D0 (sv) * | 1990-01-31 | 1990-01-31 | Britta Wahren | Monoklonal antikropp |
DE69111440T2 (de) * | 1990-04-03 | 1996-03-28 | Genentech Inc | Methoden und zusammensetzungen zur impfung gegen hiv. |
US7041293B1 (en) | 1990-04-03 | 2006-05-09 | Genentech, Inc. | HIV env antibodies |
AU8007991A (en) * | 1990-06-29 | 1992-01-23 | Daniel Zagury | Methods of inducing immune response to aids virus |
JP2989862B2 (ja) * | 1990-07-02 | 1999-12-13 | 財団法人化学及血清療法研究所 | モノクローナル抗体 |
US5712373A (en) * | 1990-07-02 | 1998-01-27 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | HIV monoclonal antibody specific for the HTLV-IIImn gp120 envelope glycoprotein |
CA2047042A1 (en) * | 1990-07-19 | 1992-01-20 | John Hannah | Cyclic hiv principal neutralizing determinant peptides |
CA2047073A1 (en) * | 1990-07-19 | 1992-01-20 | William J. Leanza | Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties |
CA2047078A1 (en) * | 1990-07-19 | 1992-01-20 | Steven S. Bondy | Cyclic hiv principal neutralizing determinant peptides |
IL99077A0 (en) * | 1990-08-13 | 1992-07-15 | Merck & Co Inc | New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them |
US5627035A (en) * | 1990-08-22 | 1997-05-06 | Syntello Vaccine Development Ab | Peptides that block human immunodeficiency virus and methods of use thereof |
US5346989A (en) * | 1990-08-22 | 1994-09-13 | Syntello Vaccine Development Kb | Peptides for use in induction of T cell activation against HIV-1 |
JPH06510025A (ja) * | 1991-06-03 | 1994-11-10 | シンテロ ヴァクシン デベロップメント アクチ ボラゲット | Hiv−1に対するt細胞活性化の誘導に用いられるペプチド |
US5558865A (en) * | 1991-08-22 | 1996-09-24 | Nissin Shokuhin Kabushiki Kaisha | HIV immunotherapeutics |
JP2888980B2 (ja) * | 1991-08-22 | 1999-05-10 | 日清食品株式会社 | Hiv免疫療法 |
WO1993010816A1 (en) * | 1991-12-02 | 1993-06-10 | Board Of Regents, The University Of Texas System | Compositions for eliciting cytotoxic t-lymphocyte responses against viruses |
IL103928A0 (en) * | 1991-12-11 | 1993-04-04 | American Home Prod | Expression of specific immunogens using viral antigens |
JPH0748276A (ja) * | 1992-03-26 | 1995-02-21 | Inmeru:Kk | Hiv感染症予防ワクチンおよびその製造法 |
WO1993019775A1 (en) * | 1992-03-31 | 1993-10-14 | Medimmune, Inc. | Administration of liposomes containing peptides or proteins including ctl eptitopes of hiv proteins |
WO1994008618A1 (en) * | 1992-10-13 | 1994-04-28 | Children's Hospital | Oral tolerance and immune suppression in the treatment of aids |
US5274122A (en) * | 1992-10-15 | 1993-12-28 | Merck & Co., Inc. | Acidic derivatives of homocysteine thiolactone |
ATE256751T1 (de) * | 1993-03-11 | 2004-01-15 | Chemo Sero Therapeut Res Inst | Monoklonaler anti-hiv antikörper |
US6180134B1 (en) | 1993-03-23 | 2001-01-30 | Sequus Pharmaceuticals, Inc. | Enhanced ciruclation effector composition and method |
US5864027A (en) * | 1993-06-07 | 1999-01-26 | Genentech, Inc. | HIV envelope polypeptides |
WO1995010777A1 (en) * | 1993-10-15 | 1995-04-20 | Rakowicz Szulczynska Ewa M | Detection and treatment of breast and gynecological cancer |
US6585979B1 (en) | 1996-07-08 | 2003-07-01 | Genentech, Inc. | HIV envelope polypeptides and immunogenic composition |
ZA975889B (en) * | 1996-07-08 | 1998-02-23 | Genentech Inc | HIV envelope polypeptides and vaccine. |
FR2874612A1 (fr) * | 2004-08-27 | 2006-03-03 | Commissariat Energie Atomique | Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications |
EP2778681A1 (en) * | 2013-03-15 | 2014-09-17 | Biomay Ag | Method for diagnosing a viral infection |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2571968B1 (fr) * | 1984-10-18 | 1989-03-17 | Pasteur Institut | Virus purifie des lymphadenopathies et du syndrome d'immuno-depression acquise et antigenes d'enveloppe de ce virus, procede d'obtention de ce virus et de ces antigenes d'enveloppe de ce virus, applications de ce virus ou de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic des susdites affections. |
GB8501473D0 (en) * | 1985-01-21 | 1985-02-20 | Pasteur Institut | Cloned dna sequences |
ES8705522A1 (es) * | 1984-10-18 | 1987-05-01 | Pasteur Institut | Un procedimiento para la preparacion de derivados purificados de una glicoproteina. |
DE3689941D1 (de) * | 1985-10-24 | 1994-08-04 | Southwest Found Biomed Res | Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc. |
WO1987007616A1 (en) * | 1986-06-12 | 1987-12-17 | Biogen N.V. | Peptides involved in the pathogenesis of hiv infection |
NZ221440A (en) * | 1986-08-20 | 1991-11-26 | Genetic Systems Corp | Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections |
CA1339857C (en) * | 1987-05-29 | 1998-05-05 | Cecily Rou-Yun Sun | Monoclonal antibodies to gp120 which neutraleze hiv-1 |
ATE138077T1 (de) * | 1988-01-26 | 1996-06-15 | Us Health | Synthetisches antigen zum bewirken einer anti-hiv-reaktion |
-
1989
- 1989-04-21 EP EP19890107197 patent/EP0339504A3/en not_active Withdrawn
- 1989-04-24 NZ NZ228869A patent/NZ228869A/en unknown
- 1989-04-24 AU AU33320/89A patent/AU632475B2/en not_active Ceased
- 1989-04-24 IL IL90058A patent/IL90058A0/xx unknown
- 1989-04-25 DK DK200189A patent/DK200189A/da not_active Application Discontinuation
- 1989-04-25 JP JP1103587A patent/JPH02160800A/ja active Pending
- 1989-04-25 FI FI891957A patent/FI891957A/fi not_active Application Discontinuation
- 1989-04-25 NO NO89891711A patent/NO891711L/no unknown
- 1989-04-25 HU HU891979A patent/HUT51296A/hu unknown
- 1989-04-26 PT PT90376A patent/PT90376B/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI891957A (fi) | 1989-10-27 |
NO891711L (no) | 1989-10-27 |
DK200189A (da) | 1989-10-27 |
DK200189D0 (da) | 1989-04-25 |
NZ228869A (en) | 1992-02-25 |
NO891711D0 (no) | 1989-04-25 |
PT90376B (pt) | 1995-01-31 |
FI891957A0 (fi) | 1989-04-25 |
EP0339504A3 (en) | 1990-09-12 |
PT90376A (pt) | 1989-11-10 |
EP0339504A2 (en) | 1989-11-02 |
AU3332089A (en) | 1989-11-02 |
AU632475B2 (en) | 1993-01-07 |
JPH02160800A (ja) | 1990-06-20 |
HUT51296A (en) | 1990-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL90058A0 (en) | Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies | |
IL103612A0 (en) | Peptides,their preparation and pharmaceutical compositions containing them | |
IL105541A0 (en) | Monoclonal antibodies to gp130 protein,processes for the preparation thereof and pharmaceutical compositions containing the same | |
NZ230199A (en) | Antibody drug conjugate, intermediates and pharmaceutical compositions | |
PH31059A (en) | Pharmaceutical compositions comprising cyclosporins. | |
NZ213566A (en) | Grf releasing peptides, and pharmaceutical compositions | |
IL72572A0 (en) | Peptides,their preparation and pharmaceutical compositions containing them | |
NZ222981A (en) | 2'-deoxy-2'2'-difluoronucleosides, antibody conjugates and pharmaceuticals containing the conjugates | |
EP0631506A4 (en) | VACCINES COMPRISING SELECTIVELY DEGLYCOSYLATED HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE PROTEINS. | |
IL89778A (en) | Unsaturated n-benzopyranyllactams, their preparation and pharmaceutical compositions containing them | |
IL84484A0 (en) | T-cell suppressor protein in pure form,its preparation by recombinant methods and pharmaceutical compositions containing it | |
IL85885A0 (en) | Cyclic peptides,their preparation and pharmaceutical compositions containing them | |
IL98769A (en) | Synthetic peptides, mixtures thereof, methods utilizing the same for detecting hiv antibodies and pharmaceutical compositions containing the same | |
IL92268A0 (en) | 14alpha,17alpha,ethanoestratriene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL85688A0 (en) | Immunoglobulin conjugates,their preparation and pharmaceutical compositions containing them | |
IL77990A (en) | Monoclonal anti-alpha-amylase antibody,process for obtaining the same and pharmaceutical compositions containing the same | |
IL86710A0 (en) | Polypeptide receptor for interleukin-2,antibodies against this polypeptide and pharmaceutical compositions containing the same | |
IL96216A0 (en) | Peptide derivatives,their preparation and pharmaceutical compositions containing them | |
IL91402A0 (en) | Aminomethyl peptides,their preparation and pharmaceutical compositions containing them | |
DE3264718D1 (en) | Piperazinoquinazoline antihypertensives, processes for preparing them, pharmaceutical compositions containing them, and immunogenic protein conjugates formed from them | |
IL92441A0 (en) | Imidazole containing peptides,their preparation and pharmaceutical compositions containing them | |
IL88743A0 (en) | Soluble recombinant fcepsilon-receptor,its preparation and pharmaceutical compositions containing it | |
IL90044A0 (en) | Imidazolylmethyl-cycloalkane(b)indolones,their preparation and pharmaceutical compositions containing them | |
NZ233255A (en) | Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope | |
EP0344211A4 (en) | MONOCLONAL ANTIBODIES IN VACCINE COMPOSITIONS. |